World’s First Human Implant of a 3D-Printed Cornea Restores Sight
December 15, 2025
Background
Erythromelalgia is a rare and frequently painful disorder affecting the extremities i.e., hands and feet.
The condition is marked by frequent episodes of intense burning pain, redness, and swelling in the affected areas.
Erythromelalgia is a condition occur due to burning pain, ranging from mild to severe and then be there constantly.
Erythromelalgia has no known cure, hence symptomatic treatment the primary management approach.
Epidemiology
Erythromelalgia is a rare disorder affecting 1 to 3 individuals per 100,000 people in total population.
Study shows presence for erythromelalgia in females, with some suggesting a higher prevalence among them.
Anatomy
Pathophysiology
Mutations in sodium channels cause increased excitability of peripheral sensory neurons, they cause spontaneous firing of nociceptive neurons, so they create burning pain.
Erythromelalgia is a condition characterized by abnormalities in the vascular system, for example dysregulation of blood flow and vascular tone.
Etiology
Primary erythromelalgia is caused by channelopathy, where ion channel destroys nerve fiber function.
Neuropathies and nerve injuries can cause abnormal sensory processing and nerve dysfunction which leads to neuropathic pain.
Genetics
Prognostic Factors
Erythromelalgia is chronic and often stays throughout life, while secondary forms may improve with treatment of the underlying condition.
Individuals with milder symptoms may have a better prognosis and experience fewer daily limitations compared to those with severe symptoms.
Clinical History
Erythromelalgia is seen in early childhood, during adolescence and in adulthood.
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Patients may experience a sudden onset of intense burning pain, redness, and warmth in their affected extremities, a temporal correlation between the onset of symptoms and exposure.
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Physical therapy and Rehabilitation services should be given to patients to improve circulation and reduce pain.
Supportive care and preventive measures along with management of complication should be carried out to improve the overall health and quality of life of patients.
Appointments with medical physicians and preventing recurrence of disorder is an ongoing life-long process.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
use-of-a-non-pharmacological-approach-for-erythromelalgiause-of-a-non-pharmacological-approach-for-erythromelalgia
Physician should encourage the patients about good hygiene practices and how to minimize exposure to infectious agents which reduces the risk of aplastic anemia.
Provide enough education about bone marrow failure syndrome and its related causes, how it spreads, and how to stop with management strategies.
Patient should avoid going in direct sunlight and hot places to minimize the heat exposures.
Apply cooling devices on affected area which includes cooling pad and ice packs to give relief from pain.
Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Aspirin: It enhances microvascular circulation hence they increase erythromelalgia symptoms and prevent thrombotic complications.It inhibits cyclooxygenase enzymes, which suppresses the production of thromboxane A2.
Anagrelide: It inhibits megakaryocyte maturation and platelet production in hematopoietic cells by inhibiting the activity of phosphodiesterase 3.
use-of-intervention-with-a-procedure-in-treating-erythromelalgia
Erythromelalgia is often treated with procedures when traditional treatments and pharmacological treatments are insufficient in alleviating symptoms.
Surgery is unlikely to be used to manage erythromelalgia except to treat the rare gangrene complication.
Sympathectomy is a procedure that involves the selective destruction or interruption of sympathetic nerve fibers to alleviate vasomotor dysfunction and enhance blood flow.
use-of-phases-in-managing-erythromelalgia
In the initial diagnosis phase, the physician assess symptoms related to bone marrow failure which is followed by appropriate diagnostic tests.
The next phase is supportive care and preventive measures where all necessary steps should be taken by physiotherapists to enhance the quality of life of the patient.
The regular follow-up visits with medical physicians are required to check the improvement of patients and newly observed complaints.
Long-term management phase is a very important phase which involves continuous monitoring, supportive care, and surveillance for late effects of treatment.
Medication
Future Trends
Erythromelalgia is a rare and frequently painful disorder affecting the extremities i.e., hands and feet.
The condition is marked by frequent episodes of intense burning pain, redness, and swelling in the affected areas.
Erythromelalgia is a condition occur due to burning pain, ranging from mild to severe and then be there constantly.
Erythromelalgia has no known cure, hence symptomatic treatment the primary management approach.
Erythromelalgia is a rare disorder affecting 1 to 3 individuals per 100,000 people in total population.
Study shows presence for erythromelalgia in females, with some suggesting a higher prevalence among them.
Mutations in sodium channels cause increased excitability of peripheral sensory neurons, they cause spontaneous firing of nociceptive neurons, so they create burning pain.
Erythromelalgia is a condition characterized by abnormalities in the vascular system, for example dysregulation of blood flow and vascular tone.
Primary erythromelalgia is caused by channelopathy, where ion channel destroys nerve fiber function.
Neuropathies and nerve injuries can cause abnormal sensory processing and nerve dysfunction which leads to neuropathic pain.
Erythromelalgia is chronic and often stays throughout life, while secondary forms may improve with treatment of the underlying condition.
Individuals with milder symptoms may have a better prognosis and experience fewer daily limitations compared to those with severe symptoms.
Erythromelalgia is seen in early childhood, during adolescence and in adulthood.
Patients may experience a sudden onset of intense burning pain, redness, and warmth in their affected extremities, a temporal correlation between the onset of symptoms and exposure.
Physical therapy and Rehabilitation services should be given to patients to improve circulation and reduce pain.
Supportive care and preventive measures along with management of complication should be carried out to improve the overall health and quality of life of patients.
Appointments with medical physicians and preventing recurrence of disorder is an ongoing life-long process.
Hematology
Physician should encourage the patients about good hygiene practices and how to minimize exposure to infectious agents which reduces the risk of aplastic anemia.
Provide enough education about bone marrow failure syndrome and its related causes, how it spreads, and how to stop with management strategies.
Patient should avoid going in direct sunlight and hot places to minimize the heat exposures.
Apply cooling devices on affected area which includes cooling pad and ice packs to give relief from pain.
Aspirin: It enhances microvascular circulation hence they increase erythromelalgia symptoms and prevent thrombotic complications.It inhibits cyclooxygenase enzymes, which suppresses the production of thromboxane A2.
Anagrelide: It inhibits megakaryocyte maturation and platelet production in hematopoietic cells by inhibiting the activity of phosphodiesterase 3.
Hematology
Erythromelalgia is often treated with procedures when traditional treatments and pharmacological treatments are insufficient in alleviating symptoms.
Surgery is unlikely to be used to manage erythromelalgia except to treat the rare gangrene complication.
Sympathectomy is a procedure that involves the selective destruction or interruption of sympathetic nerve fibers to alleviate vasomotor dysfunction and enhance blood flow.
Hematology
In the initial diagnosis phase, the physician assess symptoms related to bone marrow failure which is followed by appropriate diagnostic tests.
The next phase is supportive care and preventive measures where all necessary steps should be taken by physiotherapists to enhance the quality of life of the patient.
The regular follow-up visits with medical physicians are required to check the improvement of patients and newly observed complaints.
Long-term management phase is a very important phase which involves continuous monitoring, supportive care, and surveillance for late effects of treatment.
Erythromelalgia is a rare and frequently painful disorder affecting the extremities i.e., hands and feet.
The condition is marked by frequent episodes of intense burning pain, redness, and swelling in the affected areas.
Erythromelalgia is a condition occur due to burning pain, ranging from mild to severe and then be there constantly.
Erythromelalgia has no known cure, hence symptomatic treatment the primary management approach.
Erythromelalgia is a rare disorder affecting 1 to 3 individuals per 100,000 people in total population.
Study shows presence for erythromelalgia in females, with some suggesting a higher prevalence among them.
Mutations in sodium channels cause increased excitability of peripheral sensory neurons, they cause spontaneous firing of nociceptive neurons, so they create burning pain.
Erythromelalgia is a condition characterized by abnormalities in the vascular system, for example dysregulation of blood flow and vascular tone.
Primary erythromelalgia is caused by channelopathy, where ion channel destroys nerve fiber function.
Neuropathies and nerve injuries can cause abnormal sensory processing and nerve dysfunction which leads to neuropathic pain.
Erythromelalgia is chronic and often stays throughout life, while secondary forms may improve with treatment of the underlying condition.
Individuals with milder symptoms may have a better prognosis and experience fewer daily limitations compared to those with severe symptoms.
Erythromelalgia is seen in early childhood, during adolescence and in adulthood.
Patients may experience a sudden onset of intense burning pain, redness, and warmth in their affected extremities, a temporal correlation between the onset of symptoms and exposure.
Physical therapy and Rehabilitation services should be given to patients to improve circulation and reduce pain.
Supportive care and preventive measures along with management of complication should be carried out to improve the overall health and quality of life of patients.
Appointments with medical physicians and preventing recurrence of disorder is an ongoing life-long process.
Hematology
Physician should encourage the patients about good hygiene practices and how to minimize exposure to infectious agents which reduces the risk of aplastic anemia.
Provide enough education about bone marrow failure syndrome and its related causes, how it spreads, and how to stop with management strategies.
Patient should avoid going in direct sunlight and hot places to minimize the heat exposures.
Apply cooling devices on affected area which includes cooling pad and ice packs to give relief from pain.
Aspirin: It enhances microvascular circulation hence they increase erythromelalgia symptoms and prevent thrombotic complications.It inhibits cyclooxygenase enzymes, which suppresses the production of thromboxane A2.
Anagrelide: It inhibits megakaryocyte maturation and platelet production in hematopoietic cells by inhibiting the activity of phosphodiesterase 3.
Hematology
Erythromelalgia is often treated with procedures when traditional treatments and pharmacological treatments are insufficient in alleviating symptoms.
Surgery is unlikely to be used to manage erythromelalgia except to treat the rare gangrene complication.
Sympathectomy is a procedure that involves the selective destruction or interruption of sympathetic nerve fibers to alleviate vasomotor dysfunction and enhance blood flow.
Hematology
In the initial diagnosis phase, the physician assess symptoms related to bone marrow failure which is followed by appropriate diagnostic tests.
The next phase is supportive care and preventive measures where all necessary steps should be taken by physiotherapists to enhance the quality of life of the patient.
The regular follow-up visits with medical physicians are required to check the improvement of patients and newly observed complaints.
Long-term management phase is a very important phase which involves continuous monitoring, supportive care, and surveillance for late effects of treatment.

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
